Improving survival of octogenarian patients selected for haemodialysis

Background. The incidence of end‐stage renal disease (ESRD) among patients over the age of 80 has nearly tripled in the last decade, making the ‘old‐old’ the fastest growing ESRD demographic group. Despite this, very little information is available on the characteristics and survival of patients who...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2001-11, Vol.16 (11), p.2201-2206
Hauptverfasser: Peri, Usha N., Fenves, Andrew Z., Middleton, John P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background. The incidence of end‐stage renal disease (ESRD) among patients over the age of 80 has nearly tripled in the last decade, making the ‘old‐old’ the fastest growing ESRD demographic group. Despite this, very little information is available on the characteristics and survival of patients who initiate haemodialysis (HD) after reaching this age. Methods. We performed a retrospective study on all patients who entered an outpatient HD programme after the age of 80, from January 1988 to September 1998. A total of 106 charts were reviewed from a single nephrology practice group. Eleven patients were excluded due to incomplete data. The survival probability was calculated using the Kaplan–Meier method. Results. The characteristics of 95 patients were as follows: mean age at initiation of dialysis, 83.7 years; female, 50.5%; Caucasian, 40.0%, African–American, 30.0%; Hispanic, 10.0%; Asian, 4.3%; polytetrafluorethylene grafts, 80.0%; primary fistulas, 5.6%; tunnelled catheters, 5.6%; mean established Kt/V, 1.68; urea reduction ratio (URR), 0.74; estimated dry weight (EDW), 60.3 kg. ESRD was attributed to hypertension in 37%, diabetes in 22% and analgesic use in 8%. The 1‐, 2‐ and 5‐year survival probability of the entire group was 82.6±4.0%, 64.0±5.6%, and 19.6±6.0%, respectively. The median survival was 29 months. When comparing survival probability of patients who were in the highest quartiles of URR and EDW to those in the lowest quartile there was no discernible difference. However, the 2‐year survival probability of patients initiated after January 1, 1995 (76.9±8.4) was significantly better than those initiated from 1988–1994 (47.8±6.5; P
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/16.11.2201